The previous demonstration that a phosphonoacetate (PAA)-resistant (PAAr) vaccinia virus mutant synthesized an altered DNA polymerase provided the key to mapping this gene. Marker rescue was performed in cells infected with wild-type PAA-sensitive (PAAS) vaccinia by transfecting with calcium phosphate-precipitated DNA from a PAA' mutant virus. Formation of PAAr recombinants was measured by plaque assay in the presence of PAA. Of the 12 HindlIl fragments cloned in plasmid or cosmid vectors, only fragment E conferred the PAAr phenotype. Successive subcloning of the 15-kilobase HindIII fragment E localized the marker within a 7.5-kilobase BamHI-HindIII fragment and then within a 2.9-kilobase EcoRI fragment. When the latter was digested with ClaI, marker rescue was not detected, suggesting that the PAA' mutation mapped near a ClaI site. The sensitive ClaI site was identified by cloning partial ClaI-EcoRI fragments and testing them in the marker rescue assay. The location of the DNA polymerase gene, about 57 kilobases from the left end of the genome, was confirmed by cell-free translation of mRNA selected by hybridization to plasmids containing regions of PAAr vaccinia DNA active in marker rescue. A 100,000-dalton polypeptide that comigrated with authentic DNA polymerase was synthesized. Correspondence of the in vitro translation product with purified vaccinia DNA polymerase was established by peptide mapping.
Vaccinia virus, a member of the poxvirus family, is a large, double-stranded DNA virus that packages a complete transcription system and replicates in the cytoplasm of infected cells (26) . Recent studies of the physical structure of the 180-kilobase (kb) genome demonstrated that both ends of vaccinia DNA are hairpin loops (2, 17) and contain a 10-kb inverted repetition (16, 38) . Within this terminal repetition are sets of tandemly repeating units and the coding sequences for three early genes (1, 2, 40) . The vaccinia virus genome may code for about 180 polypeptides, of which approximately 75 early and 40 late have been mapped by cell-free translation of mRNA selected by hybridization to purified (8, 13) or cloned restriction fragments (3, 14) . However, the location of genes with known functions has just begun; thymidine kinase is the only vaccinia enzyme that has been physically mapped on the viral genome (20, 36) . The purpose of the present investigation was to map a second viral enzyme, the DNA polymerase.
A DNA polymerase with a molecular weight of 110,000 (110K) has been purified from cells infected with vaccinia virus (6) . Convincing evidence that this enzyme is virus coded came from studies with phosphonoacetate (PAA). Bolden et al. and Citarella et al. (5, 9) found that the vaccinia DNA polymerase was inhibited by PAA. In addition, Overby et al. (30) observed that high concentrations of PAA partially inhibited virus growth. Subsequently, Condit and Motyczka (11) reported the isolation of phosphonoacetateresistant (PAA') mutants of vaccinia virus. These results led Moss and Cooper (27) to demonstrate that purified DNA polymerase of PAAr virus is resistant to the drug and therefore virus coded.
In this report, we describe the mapping of the vaccinia DNA polymerase, using the technique of marker rescue (29, 34, 36) . Transfection experiments indicated that specific cloned PAAr mutant DNA fragments could recombine with PAA-sensitive (PAAS) virus DNA to form PAAr virus. The genetic location of the DNA polymerase was confirmed by in * Corresponding author.
vitro translation of mRNA selected to the region of the vaccinia genome active in marker rescue.
MATERIALS AND METHODS
Virus. Vaccinia virus (strain WR) was grown in HeLa cells and purified as described previously (21, 25) . The PAAr mutant virus used in this study has been characterized (27) .
Marker rescue. Confluent monolayers of CV-1 cells grown in Dulbecco medium supplemented with 10% fetal bovine serum were infected with PAAS virus at a multiplicity of 0.05 PFU per cell. Two hours after infection, calcium phosphateprecipitated DNA was added (18, 36 (40) , and purification of plasmid recombinants containing fragments of PAAr mutant DNA (4) have been described.
Recombinant plasmids were prepared in pBR322, pUC9 (a gift of J. Viera and J. Messing), or the cosmid pJB8 (a gift of M. Kuehl). Ligation and packaging of DNA within the cosmid were done essentially by the procedure of Grosveld et al. (19) . DNA fragments used in cloning were isolated from agarose gels by electrophoresis onto DEAE-paper (37) or by binding to powdered glass (35 Lysates were electrophoresed on 16-cm-long SDS-polyacrylamide gels, using the discontinuous system described by Laemmli (24) . The samples were electrophoresed through a 5% stacking gel and 15% resolving gel until the hemoglobin reached the bottom. After electrophoresis, the gels were soaked in En3Hance (New England Nuclear Corp.), dried under vacuum, and exposed to Kodak X-Omat XAR-5 film at -70°C.
Peptide mapping. Peptide mapping was performed essentially by the procedure of Cleveland et al. (10) . Bands of interest were excised from Coomassie blue-stained 15% polyacrylamide gels and placed in sample wells of a second SDS gel (20%:0.65% [wt/wt] acrylamide-bisacrylamide). Each slice was overlaid with various concentrations of Staphylococcus aureus V8 protease. Digestion occurred directly in the stacking gel during subsequent electrophoresis. After electrophoresis, the gel was prepared for exposure to X-ray film as described above.
Purification of [35S]methionine-labeled vaccinia virus DNA
polymerase. The basic procedure reported previously by Moss and Cooper (27) is a modification of that described by Citarella et al. (9) . Approximately 109 HeLa cells were infected with 30 PFU of vaccinia virus and labeled from 1 to 6 h postinfection with 5 mCi of [35S]methionine in medium otherwise lacking methionine and containing dialyzed horse serum and glutamine. Infected cells were Dounce homogenized and centrifuged to remove nuclei, mitochondria, and ribosomes. The supernatant was applied to a column (1.8 by 18 cm) containing DE-52 (Whatman) cellulose equilibrated with 20 mnM potassium phosphate (pH 7.5). A linear 20-to-300 mM potassium phosphate (pH 7.5) gradient in 10% glycerol-0.5 mM dithiothreitol was applied, and the 10-ml fractions collected were assayed for DNA polymerase activity (27) . Samples containing peak 1 of DNA polymerase activity were pooled and applied to a phosphocellulose (P-11, Whatman) column (1 by 5 cm) equilibrated with 0.075 M potassium phosphate (pH 7.5)-10% glycerol-1 mM dithiothreitol. After the application of a linear 0.075-to-0.5 M potassium phosphate (pH 7.5) gradient in 10% glycerol-1 mM dithiothreitol, the fractions were assayed for DNA polymerase activity and analyzed by polyacrylamide gel electrophoresis.
Materials HindIII-digested PAAr DNA fragments, the efficiency of marker rescue became equivalent to that observed with intact PAAr DNA (Table 1) . Presumably, the mixture of PAAS DNA with PAAr DNA fragments facilitated recombination. This enhancement by coprecipitation with intact viral DNA has been previously described with other markers (34; M. Ensinger, personal communication).
Analysis and cloning of PAAF mutant DNA. Restriction endonuclease analysis of DNA extracted from the PAAr mutant revealed that this virus contained a 9-kb deletion covering part of Hindlll fragments C and N. This deletion occurs spontaneously in our virus stock (28, 31) and is unrelated to the PAAr phenotype of the mutant virus. DNA extracted from several other independently isolated PAAr mutants did not contain this deletion. To identify which of the 14 HindIII DNA fragments contained the PAAr market, all except the terminal HindlIl fragments B and C were cloned in plasmid vectors for use in marker rescue experiments.
The HindIlI map of the PAAr mutant used in this study is shown in Fig. IA and is derived from that of wild-type vaccinia virus (15, 39) . The fragments D, E, F, H, I, J, K, L, M, and 0 from PAAr DNA were cloned into pUC9, and HindIII-G was inserted into pBR322. HindIII-A of vaccinia virus is 45 kb and was not previously cloned in plasmids because of its size. The development of cosmid vectors suitable for replicating DNA inserts of 30 to 45 kb (19) suggested an alternative, and we succeeded in cloning HindIII-A in the cosmid vector pJB8.
Mapping the DNA polymerase gene with the PAA' marker. The cloned PAAr HindIII fragments were used to identify the one containing the drug resistance marker ( (Table 3 ). The BaniHI restriction enzyme cleaves Hinc into three fragments of 7.5, 7, and 0.7 kb. These fragi were cloned into pUC9, and their orientation within Hi, E was determined as shown in Fig. 1B . Only the , BamHI-HindIII-A, which mapped on the right et HindIII-E, rescued PAAS virus in the presence of PAA 1B, Table 3 ).
Detailed restriction endonuclease maps of the BamHI-HindIII-A segment permitted further localizat the PAA' marker. Marker rescue was still obtained, u total EcoRI digest of the 7.5-kb BamHI-HindIII-A (Table 4) . Seven DNA pieces ranging in size from 2.9 t kb generated by EcoRI cleavage of BamHI-HindIII-A cloned in pUC9. Their arrangement within parental Bo HindIII-A was determined by end labeling and partial nuclease digestion (Fig. 1C) (Table 5 ). ClaI cleaves EcoRI-A into three 7.5-kb subfragments of approximately 1.5, 1.0, and 0.5 kb (Fig. 1D) (Fig. 1) .
Cell-free translation of RNA selected by hybridization. A DNA polymerase with a single polypeptide of about 110K -k was previously isolated from vaccinia virus-infected cells 180kb (6) . In agreement with these results, we found a major
[35S]methionine-labeled 100K polypeptide that coeluted with DNA polymerase activity (Fig. 2) . The 100K polypeptide also cosedimented with active DNA polymerase upon glycerol gradient centrifugation (data not shown).
When RNA from cycloheximide-treated vaccinia virusinfected cells was hybridized to DNA fragments containing C. (10) . RNA hybrid selected to the 7.5-kb BamHI-HindIII-A was translated in the cell-free system, and the products were electrophoresed in parallel with purified [35S]methionine-labeled vaccinia DNA polymerase. Gel bands containing the 100K protein synthesized in vitro or purified as DNA polymerase from infected cells were excised and applied directly to a second acrylamide gel in the presence of various concentrations of S. aureus V8 protease. The partial peptide map of both proteins is shown in Fig. 4 . As expected, protease digestion of this large protein generated numerous peptide fragments. Comparison by hybridization to those regions of the viral genome active in marker rescue. Vaccinia RNA that hybridized to the 15-kb HindIII-E, the 7.5-kb BamHI-HindIII, and the 2.9-kb EcoRI DNA fragments coded in vitro for a polypeptide which comigrated with the authentic viral DNA polymerase. Challberg and Englund (6) reported that the vaccinia DNA polymerase is composed of a single 110K polypeptide. Both the product synthesized in vitro and the purified in vivo DNA polymerase migrated as a lOOK protein relative to our molecular weight standards. The identity of the in vitro and in vivo DNA polymerases was confirmed by partial peptide mapping. The similarity between the products of the DNA polymerase gene synthesized in vitro and the purified enzyme suggests that the latter undergoes little, if any, posttranslational modifications.
Condit and Sridhar (personal communication) have used marker rescue to map a temperature-sensitive mutation within HindIII-E. This mutant does not synthesize DNA under nonpermissive conditions and is closely linked to a second (PAA') mutation. Thus, it seems likely that the temperature-sensitive mutation lies within the DNA polymerase gene.
The mapping of the DNA polymerase gene of vaccinia virus makes a variety of additional studies possible. By sequencing the gene, the primary structure may be determined and eventually compared with eucaryotic and other viral enzymes. Location of the PAAr mutation may help to identify and understand the active site of the enzyme. Resistance to several drugs including PAA has been mapped within a limited region thought to contain the active site of the herpesvirus DNA polymerase gene (7, 23) .
At least three temporal classes of poxvirus genes have been considered: immediate early genes expressed in the absence of de novo protein synthesis, delayed early genes expressed after synthesis of viral proteins but before DNA replication, and late genes expressed only after DNA replication. The majority of vaccinia virus polypeptides appear to be encoded by genes of the first and third classes (3, 12) . We found in the present study that mRNA encoding DNA polymerase was synthesized in the presence of cycloheximide, suggesting that this gene falls into the immediate early class. However, previous in vivo experiments suggested that the DNA polymerase of rabbitpox, a virus very closely related to vaccinia, is regulated in a delayed early fashion (22) . It is likely that the effects of virus multiplicity, cell type, and a stringency of inhibition of protein synthesis will have to be examined in a systematic fashion to further examine gene regulation. The localization of the DNA polymerase gene will allow the preparation of DNA probes for such studies.
